Bionovate Technologies Corp (BIIO)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2022 | - USD | 0.0% |
| 2021 | - USD | 100.0% |
| 2020 | -45.37 Thousand USD | -37.26% |
| 2019 | -33.05 Thousand USD | 41.54% |
| 2018 | - USD | 52.44% |
| 2017 | - USD | -35.5% |
| 2016 | -280.47 Thousand USD | -128.71% |
| 2015 | -38.36 Thousand USD | 20.42% |
| 2014 | -48.2 Thousand USD | 47.15% |
| 2013 | -91.2 Thousand USD | -4.19% |
| 2012 | -87.53 Thousand USD | -19710679309131082000.0% |
| 2011 | - USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q1 | - USD | 0.0% |
| 2022 Q1 | - USD | 0.0% |
| 2022 Q3 | - USD | 0.0% |
| 2022 Q2 | - USD | 0.0% |
| 2022 FY | - USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2021 FY | - USD | 100.0% |
| 2021 Q1 | -6279.00 USD | -43.49% |
| 2020 Q4 | -4376.00 USD | 73.77% |
| 2020 Q2 | -20.68 Thousand USD | -471.18% |
| 2020 Q1 | -3622.00 USD | 39.07% |
| 2020 FY | - USD | -37.26% |
| 2020 Q3 | -16.68 Thousand USD | 19.35% |
| 2019 Q2 | -10.95 Thousand USD | 18.36% |
| 2019 Q4 | -5945.00 USD | -116.34% |
| 2019 FY | - USD | 41.54% |
| 2019 Q1 | -13.41 Thousand USD | 24.28% |
| 2019 Q3 | -2748.00 USD | 74.9% |
| 2018 Q2 | -18.33 Thousand USD | -21.43% |
| 2018 Q4 | -17.71 Thousand USD | -228.51% |
| 2018 FY | - USD | 52.44% |
| 2018 Q1 | -15.1 Thousand USD | 51.81% |
| 2018 Q3 | -5392.00 USD | 70.59% |
| 2017 Q2 | -42.32 Thousand USD | -22.18% |
| 2017 FY | - USD | -35.5% |
| 2017 Q4 | -31.33 Thousand USD | -196.42% |
| 2017 Q3 | -10.57 Thousand USD | 75.02% |
| 2017 Q1 | -34.64 Thousand USD | -377.29% |
| 2016 FY | - USD | -128.71% |
| 2016 Q1 | -3995.00 USD | 65.29% |
| 2016 Q4 | -7258.00 USD | 75.46% |
| 2016 Q2 | -51.38 Thousand USD | -1186.31% |
| 2016 Q3 | -29.58 Thousand USD | 42.44% |
| 2015 FY | - USD | 20.42% |
| 2015 Q4 | -11.51 Thousand USD | -10.65% |
| 2015 Q1 | -9222.00 USD | 50.95% |
| 2015 Q3 | -10.4 Thousand USD | -43.99% |
| 2015 Q2 | -7225.00 USD | 21.65% |
| 2014 Q3 | -8710.00 USD | 14.72% |
| 2014 Q4 | -18.8 Thousand USD | -115.88% |
| 2014 FY | - USD | 47.15% |
| 2014 Q2 | -10.21 Thousand USD | 2.94% |
| 2014 Q1 | -10.52 Thousand USD | 65.82% |
| 2013 FY | - USD | -4.19% |
| 2013 Q2 | -25.41 Thousand USD | -66.81% |
| 2013 Q3 | -19.77 Thousand USD | 22.19% |
| 2013 Q1 | -15.23 Thousand USD | 69.74% |
| 2013 Q4 | -30.78 Thousand USD | -55.68% |
| 2012 Q2 | -5377.00 USD | -108.01% |
| 2012 Q4 | -50.34 Thousand USD | -127.52% |
| 2012 FY | - USD | -19710679309131082000.0% |
| 2012 Q1 | -2585.00 USD | -568447511560192100.0% |
| 2012 Q3 | -22.12 Thousand USD | -311.49% |
| 2011 FY | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| CVR Medical Corp. | - USD | NaN% |
| BioElectronics Corporation | -274.29 Thousand USD | 100.0% |
| IR-Med Inc. | -4.89 Million USD | 100.0% |
| Polarean Imaging plc | -11.19 Million USD | 100.0% |
| Medical Supply International USA, Inc. | 456.06 Thousand USD | 100.0% |
| Avitar, Inc. | -1.66 Million USD | 100.0% |
| AVITA Medical, Inc. | -39.56 Million USD | 100.0% |
| Manhattan Scientifics, Inc. | -1.16 Million USD | 100.0% |
| Össur hf. | 137.38 Million USD | 100.0% |
| Zecotek Photonics Inc. | -3.44 Million USD | 100.0% |
| QHSLab, Inc. | -91.29 Thousand USD | 100.0% |
| Wellstar International, Inc. | -1.35 Million USD | 100.0% |
| Össur hf. | 137.38 Million USD | 100.0% |
| EKF Diagnostics Holdings plc | 9.77 Million USD | 100.0% |
| Escalon Medical Corp. | -58.46 Thousand USD | 100.0% |
| Aurora Spine Corporation | -454.37 Thousand USD | 100.0% |
| BrainsWay Ltd. | -2.31 Million USD | 100.0% |
| Lattice Biologics Ltd. | - USD | NaN% |
| NewCardio, Inc. | -9.37 Million USD | 100.0% |
| Hamilton Thorne Ltd. | 5.52 Million USD | 100.0% |
| Vivos Inc. | -2.79 Million USD | 100.0% |
| MicroPort Scientific Corporation | -347.57 Million USD | 100.0% |
| Kelyniam Global, Inc. | -197.69 Thousand USD | 100.0% |
| REMSleep Holdings, Inc. | -1.66 Million USD | 100.0% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | 100.0% |
| Nanomix Corporation | -8.13 Million USD | 100.0% |
| Theraclion SA | -2.05 Million USD | 100.0% |
| Lifeline Biotechnologies, Inc. | - USD | NaN% |
| Wellness Center USA, Inc. | -707.03 Thousand USD | 100.0% |
| Positron Corporation | -1.45 Million USD | 100.0% |
| Rafina Innovations Inc. | - USD | NaN% |
| Electromedical Technologies, Inc. | -1.72 Million USD | 100.0% |
| Lombard Medical, Inc. | -28.06 Million USD | 100.0% |
| ALR Technologies Inc. | -6.4 Million USD | 100.0% |
| Stratec SE | 39.91 Million USD | 100.0% |
| Vycor Medical, Inc. | 100.94 Thousand USD | 100.0% |
| Heart Tronics, Inc. | -14.85 Million USD | 100.0% |
| Nu-Med Plus, Inc. | -118.25 Thousand USD | 100.0% |
| Perimeter Medical Imaging AI, Inc. | -13.27 Million USD | 100.0% |
| SANUWAVE Health, Inc. | -9.15 Million USD | 100.0% |
| VMS Rehab Systems, Inc. | -68.55 USD | 100.0% |
| Guided Therapeutics, Inc. | -3.12 Million USD | 100.0% |
| Ingen Technologies, Inc. | -8639.00 USD | 100.0% |
| Odyssey Group International, Inc. | -2.13 Million USD | 100.0% |
| United American Healthcare Corporation | -59 Thousand USD | 100.0% |
| ECGI Holdings, Inc. | -2.99 Million USD | 100.0% |
| Capital Group Holdings, Inc. | -629.18 Thousand USD | 100.0% |
| ADM Tronics Unlimited, Inc. | -514.02 Thousand USD | 100.0% |
| Urologix, Inc. | -6.34 Million USD | 100.0% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.23 Million USD | 100.0% |
| Nexeon MedSystems Inc. | -765.96 Thousand USD | 100.0% |
| SS Innovations International, Inc. | -20.37 Million USD | 100.0% |
| Qualis Innovations, Inc. | -222.81 Thousand USD | 100.0% |
| Smith & Nephew plc | 1 Billion USD | 100.0% |
| NIOX Group Plc | 11.07 Million USD | 100.0% |
| Fuse Medical, Inc. | 1.83 Million USD | 100.0% |
| Broncus Holding Corporation | -25.19 Million USD | 100.0% |
| Brain Scientific Inc. | -7.93 Million USD | 100.0% |
| Pressure BioSciences, Inc. | -9.39 Million USD | 100.0% |
| Health Logic Interactive Inc. | -18.4 Thousand USD | 100.0% |